你即將離開本站

並前往https://www.nature.com/articles/s41569-019-0282-2?proof=t%3B

Mechanisms of sacubitril–valsartan benefit in HFrEF - Nature

... Januzzi and colleagues conducted the prospective PROVE-HF trial, which included 794 patients with HFrEF, to assess whether the reduction ...

確定！ 回上一頁

查詢 「PROVE-HF」的人也找了：